A recent cohort study has revealed promising evidence that high adherence to the Mediterranean diet can lower the risk of cancers associated with obesity by 6%. This finding highlights the potential of dietary interventions in cancer prevention strategies, particularly for individuals facing obesity-related risks. The study emphasizes the importance of healthy eating patterns as a modifiable factor in reducing cancer susceptibility.
The research specifically identified that a strong commitment to the Mediterranean diet correlates with a decreased incidence of colorectal, liver, and kidney cancers. Researchers employed a tool known as the MedDiet score to assess participants' adherence to this dietary pattern. The score evaluates various factors, including moderate alcohol consumption, which is linked to higher adherence rates. Participants were categorized into groups based on their MedDiet scores, which indicated low, medium, and high adherence to the Mediterranean diet.
In addition to the MedDiet score, a relative MedDiet score was calculated, which factors in olive oil consumption using an alternate scoring method. Intriguingly, the study found that body mass index (BMI) and waist-to-hip ratios did not mediate the benefits associated with adherence to the Mediterranean diet. Researchers speculated that one reason for this finding may be the low prevalence of obesity within the study cohort.
Encouraging adherence to the Mediterranean diet could serve as a non-pharmacologic, lifestyle-based intervention for reducing cancer risk. Researchers assert that integrating dietary counseling into cancer prevention strategies is vital, especially for patients at heightened risk due to obesity or metabolic disorders. Wael Harb, MD, noted the significance of this approach:
“From a clinical perspective, this study supports integrating dietary counseling into cancer prevention strategies, particularly for patients at high risk due to obesity or metabolic disorders. Encouraging adherence to the Mediterranean diet could serve as a non-pharmacologic, lifestyle-based intervention to reduce cancer risk. This approach complements existing prevention strategies, such as weight management and exercise, and highlights the role of nutrition as a modifiable factor in cancer risk reduction. Clinicians should consider incorporating dietary education into patient care, emphasizing long-term adherence to healthy eating patterns.”
The study's authors also highlighted the need for future research to delve deeper into the biological mechanisms that underlie the association between the Mediterranean diet and reduced cancer risk. Inmaculada Aguilera-Buenosvinos, a doctoral researcher involved in the study, emphasized:
“Future studies should explore the biological mechanisms underlying this association, particularly the role of inflammation, metabolic health, and gut microbiota. Additionally, randomized controlled trials could provide more definitive evidence on the causal relationship between MedDiet adherence and cancer risk reduction. Investigating how different components of the MedDiet contribute to this protective effect will also be an important step forward.”
Dr. Anton Bilchik further reinforced the significance of dietary choices in cancer prevention:
“provides further evidence [of] how important a healthy diet low in fat, high in protein and vegetables [and] eliminating processed food is in reducing the risk of getting cancer.”
While this study contributes valuable insights into how adherence to the Mediterranean diet may serve as a protective factor against obesity-linked cancers, it also underscores the necessity for ongoing research. Understanding how various diet components interact with biological factors like inflammation and metabolic health will enhance knowledge in this field.
Leave a Reply